Sionna Therapeutics Inc stock is traded at $3.31, with a volume of 61,959. It is up +0.76% in the last 24 hours and down -30.42% over the past month. Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Previous Close:
$3.28
Open:
$3.27
24h Volume:
61,959
Relative Volume:
0.08
Market Cap:
$149.43M
Revenue:
-
Net Income/Loss:
-$85.57M
P/E Ratio:
-
EPS:
-$1.92
Net Cash Flow:
-$72.14M
1W Performance:
-14.60%
1M Performance:
-30.42%
6M Performance:
-92.37%
1Y Performance:
-90.39%
1-Day Range:
$3.25$3.36
1-Week Range:
$3.25$3.94
52-Week Range:
$3.25$54.97
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617-819-2020Address
21 HICKORY DRIVE, SUITE 500, WALTHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS